C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2011
10/13/2011	WO2011086447A3 Fermentation process for the preparation of recombinant heterologous proteins
10/13/2011	WO2011086189A3 Constructs, vectors and cyanobacteria for the synthesis of fatty alcohols, and methods for producing fatty alcohols in cyanobacteria
10/13/2011	WO2011081869A3 Method and materials for separating nucleic acid materials
10/13/2011	WO2011075806A3 Lentivirus vaccine based on the recombinant viral vaccine against yellow fever
10/13/2011	WO2011071936A3 Compositions and methods for reprogramming eukaryotic cells
10/13/2011	WO2011069487A3 Dna aptamers that specifically bind to the soluble interleukin-6 receptor
10/13/2011	WO2011068546A3 Prognosis, diagnosis and identification of multiple myeloma based on global gene expression profiling
10/13/2011	WO2011063210A3 Methods of mapping genomic methylation patterns
10/13/2011	WO2011060242A3 Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
10/13/2011	WO2011052906A3 Use of eif3m for the diagnosis and treatment of cancer
10/13/2011	WO2011049412A3 Human recombinant monoclonal antibody that specifically binds to vcam-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells
10/13/2011	WO2011049350A3 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
10/13/2011	WO2011049343A3 Methods and kits for the k-ras mutant detection using pna mediated real-tim pcr clamping
10/13/2011	WO2011049329A3 Method for producing transformed earthworms using earthworm gonad-regeneration capability, transformed earthworms thereof, and method for producing recombinant proteins from transformed earthworm body fluids
10/13/2011	WO2011046996A3 Consensus sequence for influenza a virus
10/13/2011	WO2011042901A3 Brucella phage polynucleotides and uses thereof
10/13/2011	WO2011040738A3 Intracellular viral vector delivery method employing iron ion/viral vector composite
10/13/2011	WO2011031568A3 A NOVEL PROTEIN DELIVERY SYSTEM TO GENERATE INDUCED PLURIPOTENT STEM (iPS) CELLS OR TISSUE-SPECIFIC CELLS
10/13/2011	WO2010103284A8 Diagnosis and treatment of cell proliferation and differentiation disorders based on the fmn2 gene
10/13/2011	WO2010001417A3 Use of plant-derived recombinant growth factors in skin care
10/13/2011	US20110252509 Method for Producing a Transgenic Cell with Increased Gamma-Aminobutyric Acid (Gaba) Content
10/13/2011	US20110252508 Plants Having Enhanced Yield-Related Traits and/or Abiotic Stress Tolerance and a Method for Making the Same
10/13/2011	US20110252507 Transgenic plants used as a bioreactor system
10/13/2011	US20110252506 Promotion of somatic embryogenesis in plants by wuschel gene expression
10/13/2011	US20110252505 Down-Regulation of ACC Synthase for Improved Plant Performance
10/13/2011	US20110252504 Promoter From Z. Mais
10/13/2011	US20110252503 Plants With Improved Nitrogen Utilization and Stress Tolerance
10/13/2011	US20110252502 Grg23 epsp synthases: compositions and methods of use
10/13/2011	US20110252498 Soybean Cultivar 1000679
10/13/2011	US20110252497 Soybean Cultivar S090244
10/13/2011	US20110252496 Soybean Cultivar 86237173
10/13/2011	US20110252495 Soybean Cultivar 89126133
10/13/2011	US20110252494 Soybean Cultivar S090247
10/13/2011	US20110252493 Soybean Cultivar 8012419
10/13/2011	US20110252492 Soybean cultivar 8029288
10/13/2011	US20110252491 Chimeric plant promoters and their uses in plants
10/13/2011	US20110252489 Method of identifying prolificacy in mammals
10/13/2011	US20110252486 Chondrocyte-like cell, and method for producing same
10/13/2011	US20110251382 Isolation of nucleic acid
10/13/2011	US20110251376 Mammalian Tumor Susceptibility Genes and their Uses
10/13/2011	US20110251267 Methods of using polynucleotides encoding truncated glial cell line-derived neurotrophic factor
10/13/2011	US20110251265 Polyamine-containing polymers and methods of synthesis and use
10/13/2011	US20110251264 Transcription factor decoys
10/13/2011	US20110251263 RNAi Modulation of the BCR-ABL Fusion Gene and Uses Thereof
10/13/2011	US20110251262 Compositions And Methods For Inhibiting Expression Of An RNA From West Nile Virus
10/13/2011	US20110251260 NOVEL siRNAS AND METHODS OF USE THEREOF
10/13/2011	US20110251259 Compositions and methods for inhibiting expression of cd274/pd-l1 gene
10/13/2011	US20110251258 Rnai constructs and uses thereof
10/13/2011	US20110251257 Methods and compositions for treating neurological disease
10/13/2011	US20110251150 Targeting MicroRNAs For The Treatment Of Liver Cancer
10/13/2011	US20110251140 Peptide antagonist of interleukin-15 activity
10/13/2011	US20110251130 Methods and Compositions for Promoting Bone Growth
10/13/2011	US20110251122 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
10/13/2011	US20110251117 Alpha-amylase mutants
10/13/2011	US20110251109 Fluidic methods for devices for parallel chemical reactions
10/13/2011	US20110251108 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/13/2011	US20110251107 G-quadruplex binding assays and compounds therefor
10/13/2011	US20110251106 Pvii phage display
10/13/2011	US20110251095 Mara family helix-turn-helix domains and their methods of use
10/13/2011	US20110251076 Non-invasive detection of fetal genetic traits
10/13/2011	US20110251073 Compositions And Methods Comprising Variant Microbial Proteases
10/13/2011	US20110250703 Il1rl-1 as a cardiovascular disease marker and therapeutic target
10/13/2011	US20110250694 Eukaryotic expression vectors resistant to transgene silencing
10/13/2011	US20110250693 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
10/13/2011	US20110250692 Method for producing induced pluripotent stem cells
10/13/2011	US20110250685 Compositions and methods for enhancing cellular transport of biomolecules
10/13/2011	US20110250675 Virus-Like Particle Mediated Cellular Delivery
10/13/2011	US20110250674 Cellulase variants
10/13/2011	US20110250672 Mutant dna polymerases and uses therof
10/13/2011	US20110250671 Glucose dehydrogenase and method for producing the dehydrogenase
10/13/2011	US20110250669 Method and apparatus for selectively targeting specific cells within a cell population
10/13/2011	US20110250659 Modified photosynthetic microorganisms for producing lipids
10/13/2011	US20110250655 Biocatalysts For Manufacturing Duloxetine Alcohol
10/13/2011	US20110250653 L-succinylaminoacylase and process for producing l-amino acid using it
10/13/2011	US20110250650 Lentiviral vectors for the preparation of immunotherapeutical compositions
10/13/2011	US20110250636 Novel gene GMS 01
10/13/2011	US20110250631 Proteoglycan degrading mutants for treatment of cns
10/13/2011	US20110250630 Motif-grafted hybrid polypeptides and uses thereof
10/13/2011	US20110250609 Methods For The Detection, Analysis And Isolation Of Nascent Proteins
10/13/2011	US20110250608 Use of ultraconserved rna in detection and treatment of cancer
10/13/2011	US20110250591 METHOD OF DESIGNING siRNAS FOR GENE SILENCING
10/13/2011	US20110250583 Optimized probes and primers and methods of using same for the binding, detection, differentiation, isolation and sequencing of influenza a; influenza b; novel influenza a/h1n1; and a novel influenza a/h1n1 rna sequence mutation associated with oseltamivir resistance
10/13/2011	US20110250345 Soybean Cultivar S090252
10/13/2011	US20110250342 PUFA Polyketide Synthase Systems and Uses Thereof
10/13/2011	US20110250261 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
10/13/2011	US20110250260 Inhibition of brain enzymes inolved in cerebral amyloid angiopathy and macular degeneration
10/13/2011	US20110250258 Tumor-specific delivery of therapeutic agents via liposomase
10/13/2011	US20110250234 Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof
10/13/2011	US20110250232 DNA-Transfection System for the Generation of Infectious Influenza Virus
10/13/2011	US20110250230 Cell capable of expressing exogenous gitr ligand
10/13/2011	US20110250228 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
10/13/2011	US20110250223 Hybrid and tandem expression of neisserial proteins
10/13/2011	US20110250221 Group A Streptococcus Pharmaceutical Compositions and Methods Thereof
10/13/2011	US20110250219 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
10/13/2011	US20110250211 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
10/13/2011	US20110250210 Neutralizing Antibodies and Fragments Thereof Directed Against Platelet Factor-4 Variant 1 (PF4V1)
10/13/2011	US20110250207 Anti-fxi antibodies and methods of use
10/13/2011	US20110250200 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling
10/13/2011	US20110250195 Antibodies Against IL-25
10/13/2011	US20110250194 Treatment with Anti-ErbB2 Antibodies

1 ... 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 ... 4023